European Patent and Design Attorney at Aera
Marianne Johansen entered the IP profession in 1989 after having worked as an associate professor at the University of Copenhagen for several years. She has a PhD in drug delivery systems and has a profound knowledge of life sciences, including pharmaceutical chemistry, pharmaceutical formulation, drug delivery systems, diagnostics, biomarkers, medicine, pharmacology, biochemistry, biotechnology, stem cell technology, immunotherapy, immunology and cell therapy. In addition, she has extensive knowledge and experience in all IP aspects of these technical fields.
Beside the traditional aspects of intellectual property (eg, managing IP portfolios, pre-evaluation of possible IP protection of new projects, establishment of IP rights, oppositions and appeals, litigation of IP rights), Ms Johansen’s practice focuses on the interface between IP protection and market/data exclusivity, especially within the pharmaceutical field. An important issue for her is also all strategic aspects of IP rights and she has successfully advised many clients on IP strategy focused on their business strategy.
During her IP career she has held several CEO positions, while always maintaining a close relationship with her clients and carrying on handling IP work personally for them – a challenging task that requires skills in science, languages and communication, legal matters, business and creativity.
Ms Johansen is a highly esteemed adviser for large, medium and small-sized companies, as well as for university-based clients, both globally and locally. She has been lead IP adviser for several companies, involved in public offering, mergers and acquisitions, and licensing, as well as in due diligence processes.
Besides her IP work, Ms Johansen is an external lecturer at the University of Copenhagen and a technical judge at the Maritime and Commercial High Court and the Western High Court.